Department of Public Health and Preventive Medicine, Medical School, Jinggangshan University, China.
Thoracic Surgery, First Affiliated Hospital of Nanchang University, China.
J Immunol Res. 2022 Aug 8;2022:1932692. doi: 10.1155/2022/1932692. eCollection 2022.
To investigate the effect and mechanism of curcumin (CUR) killing lung cancer HCC827 cell spheres.
HCC827 cell spheres were cultured in serum-free medium, and the protein expression of CD133, SOX2, EpCAM, and ABCG2 was detected by western blot. MTT was used to evaluate the cell viability of HCC827 cell spheres and HCC827 cell after they were treated by 1, 2, 5, 10, and 20 mg/mL carboplatin (CBP) for 48 h. The inhibitory effects of 10 M, 50 M, 100 M, and 200 M CUR on GST (glutathione S-transferase) activity in HCC827 cell spheres were determined by colorimetry. The flow cytometry (FCM), western blot, qPCR, luciferase assay, and microscopy were used to detect the ROS levels, cell pelletization ability, -catenin, SOX2, and ABCG2 mRNA and the promoter activity of -catenin upon of HCC827 cell spheres treated with 200 M CUR for 48 h. The HCC827 cell spheres were infected with -catenin adenovirus, and then cells were treated with 200 M CUR (and/or no 5 mg/mL CBP) for 24 h. The mRNA and protein expression of -catenin, SOX2, and ABCG2 was detected by qPCR and western blot, and cell growth inhibition of HCC827 cell spheres was evaluated by MTT.
The expression of stem cells marker CD133, SOX2, EpCAM, and drug resistance-related gene ABCG2 mRNA is higher in HCC827 cell spheres, and HCC827 cell spheres resisted the killing effect of difference doses of CBP. The activity of GST of HCC827 cell spheres was inhibited by 10 M, 50 M, 100 M, and 200 M CUR. It was a dose-dependent manner. After 200 M CUR had treated HCC827 cell spheres for 48 h, the level of ROS was significantly increased ( < 0.05), and the mRNA and protein expression of -catenin, SOX2, and ABCG2 and promoter activity of -catenin were notably decreased ( < 0.05), compared to the control group. Furthermore, the formed-sphere ability of HCC827 sphere was inhibited after cells were treated with 200 M CUR. 200 M CUR could suppress the proliferation of HCC827 cell spheres and induced cell apoptosis. The proliferation of HCC827 cell spheres was significantly inhibited, and cell apoptosis rate was increased by 200 M CUR combined with 5 mg/mL CBP than by 200 M CUR alone. Upregulation of -catenin by adenovirus partly reversed the effect of CUR inhibition of the expression of -catenin, SOX2, and ABCG2, compared to empty vector adenovirus group. Additionally, overexpression of -catenin significantly remitted the inhibitory effect of 200 M CUR combined with 5 mg/mL CBP on the proliferation of HCC827 cell spheres.
CUR inhibited the cell proliferation and stem cell trait and induced apoptosis in HCC827 cell spheres by the inhibition of GST activity and -catenin expression. CUR is expected to become a treatment for lung cancer and lung cancer stem cells.
研究姜黄素(CUR)杀伤肺癌 HCC827 细胞球的作用及其机制。
无血清培养基培养 HCC827 细胞球,采用 Western blot 检测 CD133、SOX2、EpCAM 和 ABCG2 蛋白的表达。MTT 法检测 1、2、5、10 和 20 mg/ml 卡铂(CBP)处理 HCC827 细胞球和 HCC827 细胞 48 h 后的细胞活力。采用比色法测定 10、50、100 和 200 μM CUR 对 HCC827 细胞球 GST(谷胱甘肽 S-转移酶)活性的抑制作用。流式细胞术(FCM)、Western blot、qPCR、荧光素酶检测和显微镜观察,检测 200 μM CUR 处理 HCC827 细胞球 48 h 后 ROS 水平、细胞团块形成能力、β-catenin、SOX2 和 ABCG2 mRNA 以及β-catenin 启动子活性。用β-catenin 腺病毒感染 HCC827 细胞球,然后用 200 μM CUR(和/或无 5 mg/ml CBP)处理 24 h。用 qPCR 和 Western blot 检测β-catenin、SOX2 和 ABCG2 的 mRNA 和蛋白表达,并用 MTT 评估 HCC827 细胞球的生长抑制率。
与 HCC827 细胞相比,HCC827 细胞球中干细胞标志物 CD133、SOX2、EpCAM 和耐药相关基因 ABCG2 mRNA 的表达水平更高,且 HCC827 细胞球对不同剂量 CBP 的杀伤作用有抵抗。10、50、100 和 200 μM CUR 可抑制 HCC827 细胞球的 GST 活性。200 μM CUR 处理 HCC827 细胞球 48 h 后,ROS 水平显著升高(<0.05),β-catenin、SOX2 和 ABCG2 的 mRNA 和蛋白表达以及β-catenin 启动子活性明显降低(<0.05),与对照组相比。此外,用 200 μM CUR 处理细胞后,HCC827 球的形成能力受到抑制。200 μM CUR 可抑制 HCC827 细胞球的增殖并诱导细胞凋亡。与单独使用 200 μM CUR 相比,200 μM CUR 联合 5 mg/ml CBP 可显著抑制 HCC827 细胞球的增殖,增加细胞凋亡率。用腺病毒上调β-catenin 后,与空载体腺病毒组相比,CUR 抑制β-catenin、SOX2 和 ABCG2 表达的作用部分逆转。此外,过表达β-catenin 可显著减轻 200 μM CUR 联合 5 mg/ml CBP 对 HCC827 细胞球增殖的抑制作用。
CUR 通过抑制 GST 活性和β-catenin 表达抑制 HCC827 细胞球的细胞增殖和干细胞特性,并诱导细胞凋亡。CUR 有望成为治疗肺癌和肺癌干细胞的一种方法。